Optimal timing of surgery for locally advance rectal cancer: how we choose
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 3
Abstract
Locally advanced rectal cancer (LARC) is associated with a high risk of local recurrence and distant metastasis, making it difficult to be cured by surgery alone. Neoadjuvant chemoradiotherapy followed by surgery is the standard treatment for LARC, with reduced local recurrence rates. However, neoadjuvant chemoradiotherapy is associated with patients' urogenital and sexual dysfunction, which severely affecting their quality of life. Therefore, determining the optimal timing of surgery to balance oncologic and functional outcomes is crucial and challenging. We proposed that choosing the optimal timing of surgery based on preoperative risk assessment of LARC is an effective strategy. The patients with low to moderate risk of recurrence can be considered to perform surgery directly or have preoperative chemotherapy followed by radical surgery. Patients with high risk of recurrence should extend neoadjuvant therapy before surgery to improve oncologic outcomes. In this study we explored the optimal timing of radical surgery for LARC, providing a new idea for individualized and precise treatment of LARC.
Authors and Affiliations
Haiting XIE, Yeting HU, Jun LI, Kefeng DING
Keywords
Related Articles
- EP ID EP750965
- DOI 10.16139/j.1007-9610.2024.03.04
- Views 19
- Downloads 1
<![CDATA[Research status and prospects of colorectal cancer vaccine]]>
<![CDATA[Colorectal cancer(CRC) ranks in third place in terms of incidence but second in terms of mortality. Cancer vaccine, as a novel immunotherapy, presents tumor antigens to human immune system and further elicits an...
Role of the spleen in patients with liver cancer and cirrhosis
The spleen is the largest lymphoid organ that can affect the immunological microenvironment in the liver via the portal system. Patients with liver cancer, often develop hypersplenism and splenomegaly from underlying cir...
Perioperative blood volume monitoring and therapy
Perioperative blood volume monitoring and treatment is an important part of clinical anesthesia, which is essential for restoring effective blood volume, ensuring oxygen supply to organs and tissues, and stabilizing the...
Systemic therapy alters the landscape of surgery in hepatocellular carcinomaļ¼ opportunities and challenges
Surgery is still the first choice for patients with hepatocellular carcinoma(HCC). However, about 70% of HCC patients in China are first diagnosed in the advanced stage and have lost the opportunity for surgery. Recently...
Papillary thyroid microcarcinoma should not be used as the basis for postoperative 131I therapy
[Objective] To analyze the clinicopathological data of patients with papillary thyroid microcarcinoma (PTMC) and papillary thyroid non-microcarcinoma (non-PTMC) who received 131I therapy retrospectively, and compare th...